Track topics on Twitter Track topics that are important to you
VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 07/21/15 -- Aurora Cannabis Inc. (CSE: ACB) (FRANKFURT: 21P)(WKN: A1C4WM)(OTCQB: ACBFF) ("Aurora" or the "Company") is pleased to announce that its common shares commenced trading today on the OTCQB®, under the symbol "ACBFF". Real-time quotes and market information on the Company are available at www.otcmarkets.com/stock/ACBFF/quote. Baxter Capital Advisers, Inc., an Arizona based broker-dealer, acted as the Company's OTCQB sponsor and advisor.
The OTCQB, a US trading platform operated by the OTC Markets Group in New York, is a venture stage marketplace for early-stage and developing U.S. and international companies. Companies are required to meet eligibility standards aimed at improving the information available to investors. OTCQB includes real-time level 2 quotes and the OTC disclosure and news service to help companies improve information experience to their investors.
Terry Booth, CEO of Aurora, commented, "We are very pleased with this new listing on the OTCQB Venture Marketplace. The listing will increase Aurora's presence with American retail and institutional investors, thus providing enhanced liquidity to the Company's expanding shareholder base."
Aurora's common shares continue to trade on the Canadian Securities Exchange under the symbol "ACB".
About Aurora Cannabis Inc.
Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical marijuana pursuant to the Marihuana for Medical Purposes Regulations and operates a 55,200 square foot expandable state-of-the-art production facility in Alberta, Canada. Aurora's wholly-owned subsidiary, Australis Capital Inc., seeks to be an active participant in the U.S. Cannabis market. Aurora is trading on the Canadian Securities Exchange under the trading symbol "ACB".
On behalf of the Board of Directors,
AURORA CANNABIS INC.
Terry Booth, CEO
The CSE, securities commission or other regulatory authority has not reviewed, approved or disapproved the contents of this press release. We seek Safe Harbour.Contacts: Aurora Cannabis Inc. Investor Relations Paul J. Searle Toll Free: 1-844-928-7672 or (604) 669-9788 (604) 669-9768 (FAX) Aurora Cannabis Inc. Media Inquiries Elise Coppens Marketing Director Toll Free: 1-844-928-7672 (FAX) NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...